GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » Revenue

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Revenue : ¥858.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co Revenue?

Qianjiang Yongan Pharmaceutical Co's revenue for the three months ended in Mar. 2024 was ¥196.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥858.4 Mil. Qianjiang Yongan Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.67. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.93.

Warning Sign:

Qianjiang Yongan Pharmaceutical Co Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Qianjiang Yongan Pharmaceutical Co was -36.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was -6.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Qianjiang Yongan Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 34.50% per year. The lowest was -11.60% per year. And the median was 8.10% per year.


Qianjiang Yongan Pharmaceutical Co Revenue Historical Data

The historical data trend for Qianjiang Yongan Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianjiang Yongan Pharmaceutical Co Revenue Chart

Qianjiang Yongan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,370.44 1,172.85 1,565.41 1,462.45 972.89

Qianjiang Yongan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 311.17 267.27 224.38 170.07 196.65

Competitive Comparison of Qianjiang Yongan Pharmaceutical Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Qianjiang Yongan Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianjiang Yongan Pharmaceutical Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianjiang Yongan Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Qianjiang Yongan Pharmaceutical Co's Revenue falls into.



Qianjiang Yongan Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥858.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qianjiang Yongan Pharmaceutical Co  (SZSE:002365) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Qianjiang Yongan Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100
Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.
Executives
Mei Song Lin Executives
Wang Zhi Hua Executives
Hong Ren Gui Executives
Wu Yu Xi Directors, executives
Dai Xiang Zhen Executives
Wu Xiao Bo Directors, executives
Luo Bai Neng Executives
Ding Hong Li Directors, executives
Fang Xi Quan Executives
Li Shao Bo Executives
Deng Yong Hong Securities Affairs Representative
Dong Shi Hao Executives
Wu Guo Sen Supervisors
Lv Xin Wu Executives
Chen Yong Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines